IN8bio, Inc. (INAB)
Nasdaq: INAB · Biological Products, (No Diagnostic Substances) · New York, NY · filing with the SEC since 2018
Who owns IN8bio, Inc.
As filed with the SECHolders of 5% or more
5
Lytton Laurence W holds 9.99% of Common Stock, as its SCHEDULE 13G/A filed Aug 13, 2026 says.
Directors and officers
10
report now, of 28 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Lytton Laurence W
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock · 9.99% in Mar 2, 2026
Alyeska Investment Group, L.P.
SCHEDULE 13G · filed Feb 17, 2026 · Common Stock, $0.0001 par value per share · 2.58% in Aug 14, 2025
Stonepine Capital Management, LLC
SCHEDULE 13G · filed Dec 22, 2025 · Common Stock
Franklin Resources, Inc.
SCHEDULE 13G · filed Jan 29, 2026 · Common Stock, $0.0001 par value per share
683 Capital Management, LLC
SCHEDULE 13G · filed Dec 30, 2025 · Common Stock, $0.0001 par value per share
Orin Hirschman
SCHEDULE 13G/A · filed Jul 29, 2025 · Common Stock, $0.0001 Par Value Per Share · reported falling below 5%, from 8.5% in Jan 31, 2025
BIOS Capital Management, LP
SCHEDULE 13D/A · filed Dec 29, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.99% in May 8, 2025
William Tai-Wei Ho
SCHEDULE 13G/A · filed Aug 13, 2025 · Common Stock, $0.0001 Par Value Per Share · reported falling below 5%, from 5.6% in Feb 14, 2025
Transcend Partners Opportunity Fund LLC
SCHEDULE 13G/A · filed Aug 13, 2025 · Common Stock, $0.0001 Par Value Per Share · reported falling below 5%
Emily Fairbairn
SCHEDULE 13D/A · filed May 29, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 7.5% in Jan 2, 2026
What INAB reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
U A B R F
An investee · investee · invested in, named in the 10-K filed Mar 12, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2023 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.